article thumbnail

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

Data for this investigation were sourced from a community-based approach, utilizing information from CHS, which integrates data from community sources and hospitals. Population: Jewish CHS members, aged 18+, diagnosed with T2D between 2000-2011, born in Israel or Ethiopia. Intervention: 10-year follow-up to track T2D outcomes.

article thumbnail

Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics

FDA Law Blog

She also specializes in medical device software and digital health. Jennifer was with the firm from 2011-2017, before leaving for in-house roles at Apple, Abbott Laboratories, and Cognito Therapeutics. Jennifer also helps clients with contract matters, regulatory due diligence, and public filings. Ellison, Managing Director at HPM.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Our esteemed publications should ensure that investigations that utilize racial variables follow these guidelines before being published. Examining the Potential Impact of Race Multiplier Utilization in Estimated Glomerular Filtration Rate Calculation on African-American Care Outcomes. 2011 Sep 20;155(6):408]. doi:10.1001/jama.2019.577

Clinic 52
article thumbnail

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog

No reasonable jury could have concluded that the carved-out labeling for petitioner’s generic carvedilol from 2007-2011 was itself evidence of intent to induce infringement.” Plainly, the Government brief states “The decision below is incorrect. Whether the Court takes up Teva v. GSK is still up in the air.

article thumbnail

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

GeriPal

We got some really special guests with us. And so that lends it properties of being a pretty strong analgesic and it lends its special properties for safety, from a safety profile. I always thought this article came out 2011. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Transcript.

Illness 102